4.6 Article

Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 17, Issue 25, Pages 2685-2698

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986710791859315

Keywords

Copper; oxidative stress; proteasome inhibitor; ROS; angiogenesis

Funding

  1. NCI NIH HHS [R21 CA139386, P30CA027165, 1R01CA120009, 1R21CA139386-01, R01 CA120009] Funding Source: Medline

Ask authors/readers for more resources

Copper is an essential element for multiple biological processes. Its concentration is elevated to a very high level in cancer tissues for promoting cancer development through processes such as angiogenesis. Organic chelators of copper can passively reduce cellular copper and serve the role as inhibitors of angiogenesis. However, they can also actively attack cellular targets such as proteasome, which plays a critical role in cancer development and survival. The discovery of such molecules initially relied on a step by step synthesis followed by biological assays. Today high-throughput chemistry and high-throughput screening have significantly expedited the copper-binding molecules discovery to turn cancer-promoting copper into anti-cancer agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available